These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 3129850)
1. Effect of orchidectomy performed after cessation of estrogen therapy on serum testosterone concentrations in patients with prostatic carcinoma. Tomić R; Damber JE Urol Int; 1987; 42(6):441-4. PubMed ID: 3129850 [TBL] [Abstract][Full Text] [Related]
2. Pituitary function after orchiectomy in patients with or without earlier estrogen treatment for prostatic carcinoma. Tomić R J Endocrinol Invest; 1987 Oct; 10(5):479-82. PubMed ID: 3123547 [TBL] [Abstract][Full Text] [Related]
3. The effects of orchidectomy, estrogens, and cyproterone acetate on plasma testosterone, LH, and FSH concentrations in patients with carcinoma of the prostate. Varenhorst E; Wallentin L; Carlström K Scand J Urol Nephrol; 1982; 16(1):31-6. PubMed ID: 6211762 [TBL] [Abstract][Full Text] [Related]
4. Hormonal effects of cessation of estrogen treatment for prostatic carcinoma. Tomić R; Bergman B J Urol; 1987 Oct; 138(4):801-3. PubMed ID: 3116281 [TBL] [Abstract][Full Text] [Related]
5. [Change of serum adrenal androgens in prostatic cancer patients after bilateral orchidectomy or LHRH agonist treatment]. Oka H; Negoro H; Sugino Y; Iwamura H; Moroi S; Kawakita M Hinyokika Kiyo; 2003 Sep; 49(9):521-5. PubMed ID: 14598689 [TBL] [Abstract][Full Text] [Related]
6. Effects of total and subcapsular orchidectomy on serum concentrations of testosterone and pituitary hormones in patients with carcinoma of the prostate. Bergman B; Damber JE; Tomić R Urol Int; 1982; 37(2):139-44. PubMed ID: 6810527 [TBL] [Abstract][Full Text] [Related]
7. Some effects of orchiectomy, oestrogen treatment and radiation therapy in patients with prostatic carcinoma. Tomić R Scand J Urol Nephrol Suppl; 1983; 77():1-37. PubMed ID: 6426040 [TBL] [Abstract][Full Text] [Related]
8. Serum bioactive and immunoreactive follicle-stimulating hormone in prostatic cancer patients during gonadotropin-releasing hormone agonist treatment and after orchidectomy. Huhtaniemi IT; Dahl KD; Rannikko S; Hsueh AJ J Clin Endocrinol Metab; 1988 Feb; 66(2):308-13. PubMed ID: 3123510 [TBL] [Abstract][Full Text] [Related]
9. Influence of orchidectomy or oestrogen treatment on serum levels of pregnancy associated alpha 2-glycoprotein and sex hormone binding globulin in patients with prostatic cancer. Carlström K; Eriksson A; Gustafsson SA; Henriksson P; Pousette A; Stege R; von Schoultz B Int J Androl; 1985 Feb; 8(1):21-7. PubMed ID: 3922901 [TBL] [Abstract][Full Text] [Related]
10. Binding capacity of testosterone-estradiol-binding globulin (TeBG), total and calculated unbound concentrations of testosterone in patients with carcinoma of the prostate treated with orchidectomy or estrogens. Damber JE; Bergman B; Södergård R; Tomić R J Endocrinol Invest; 1983 Apr; 6(2):91-4. PubMed ID: 6683289 [TBL] [Abstract][Full Text] [Related]
11. Effect of orchidectomy on serum concentrations of testosterone and dihydrotestosterone in patients with prostatic cancer. Røhl HF; Beuke HP Scand J Urol Nephrol; 1992; 26(1):11-4. PubMed ID: 1631501 [TBL] [Abstract][Full Text] [Related]
12. Testicular endocrine function after withdrawal of oestrogen treatment in patients with carcinoma of the prostate. Tomić R; Bergman B; Damber JE Br J Urol; 1983 Feb; 55(1):42-7. PubMed ID: 6402048 [TBL] [Abstract][Full Text] [Related]
13. Adrenocortical function in prostatic cancer patients: effects of orchidectomy or different modes of estrogen treatment on basal steroid levels and on the response to exogenous adrenocorticotropic hormone. Carlström K; Stege R Urol Int; 1990; 45(3):160-3. PubMed ID: 2161578 [TBL] [Abstract][Full Text] [Related]
14. Individual variation of hormonal recovery after cessation of luteinizing hormone-releasing hormone agonist therapy in men receiving long-term medical castration therapy for prostate cancer. Kobayashi T; Nishizawa K; Mitsumori K Scand J Urol Nephrol; 2006; 40(3):198-203. PubMed ID: 16809259 [TBL] [Abstract][Full Text] [Related]
15. Influence of continuous luteinizing hormone-releasing hormone agonist treatment on steroidogenic enzymes in the human testis. Petersson F; Hammar M; Mathson K; Hjertberg H; Varenhorst E Scand J Urol Nephrol; 1987; 21(4):267-71. PubMed ID: 2965409 [TBL] [Abstract][Full Text] [Related]
16. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production. Matsumoto AM J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626 [TBL] [Abstract][Full Text] [Related]
17. Long term follow-up of patients with advanced prostatic cancer treated with nasal buserelin. Falkson CI; Falkson G; Falkson HC Ann Oncol; 1991 Apr; 2(4):303-4. PubMed ID: 1907843 [TBL] [Abstract][Full Text] [Related]
18. [Value of testosterone, FSH and LH on plasma in patients with prostatic adenoma and carcinoma before and after different hormonal treatments]. Garcia de la Peña E; Ramos F; Horcajada C; Cifuentes Delatte L; Vivanco F Rev Clin Esp; 1978 Jan; 148(1):19-23. PubMed ID: 76325 [No Abstract] [Full Text] [Related]
19. Changes in the qualitative and quantitative secretion of luteinizing hormone (LH) following orchidectomy in man. Tsatsoulis A; Shalet SM; Robertson WR Clin Endocrinol (Oxf); 1988 Aug; 29(2):189-94. PubMed ID: 3150321 [TBL] [Abstract][Full Text] [Related]
20. Response of circulating gonadotropin levels to GnRH agonist treatment in prostatic cancer. Huhtaniemi I; Venho P; Jacobi G; Rannikko S J Androl; 1991; 12(1):46-53. PubMed ID: 1901309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]